Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 207

1.

Special Issue: Rabies Symptoms, Diagnosis, Prophylaxis, and Treatment.

Rupprecht CE, Dietzschold B.

Trop Med Infect Dis. 2017 Nov 14;2(4). pii: E59. doi: 10.3390/tropicalmed2040059.

2.

The phenotype of the RABV glycoprotein determines cellular and global virus load in the brain and is decisive for the pace of the disease.

Bertoune MAR, Nickl B, Krieger T, Wohlers L, Bonaterra GA, Dietzschold B, Weihe E, Bette M.

Virology. 2017 Nov;511:82-94. doi: 10.1016/j.virol.2017.08.019. Epub 2017 Aug 23.

3.

Pathogenicity and Immunogenicity of Recombinant Rabies Viruses Expressing the Lagos Bat Virus Matrix and Glycoprotein: Perspectives for a Pan-Lyssavirus Vaccine.

Kgaladi J, Faber M, Dietzschold B, Nel LH, Markotter W.

Trop Med Infect Dis. 2017 Aug 9;2(3). pii: E37. doi: 10.3390/tropicalmed2030037.

4.

Limited brain metabolism changes differentiate between the progression and clearance of rabies virus.

Schutsky K, Portocarrero C, Hooper DC, Dietzschold B, Faber M.

PLoS One. 2014 Apr 24;9(4):e87180. doi: 10.1371/journal.pone.0087180. eCollection 2014.

5.

Intramuscular inoculation of mice with the live-attenuated recombinant rabies virus TriGAS results in a transient infection of the draining lymph nodes and a robust, long-lasting protective immune response against rabies.

Schutsky K, Curtis D, Bongiorno EK, Barkhouse DA, Kean RB, Dietzschold B, Hooper DC, Faber M.

J Virol. 2013 Feb;87(3):1834-41. doi: 10.1128/JVI.02589-12. Epub 2012 Nov 28.

6.
7.

The role of toll-like receptors in the induction of immune responses during rabies virus infection.

Li J, Faber M, Dietzschold B, Hooper DC.

Adv Virus Res. 2011;79:115-26. doi: 10.1016/B978-0-12-387040-7.00007-X. Review.

PMID:
21601045
8.

Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine.

Henderson H, Jackson F, Bean K, Panasuk B, Niezgoda M, Slate D, Li J, Dietzschold B, Mattis J, Rupprecht CE.

Vaccine. 2009 Nov 27;27(51):7194-7. doi: 10.1016/j.vaccine.2009.09.030.

PMID:
19925952
9.

Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans.

Müller T, Dietzschold B, Ertl H, Fooks AR, Freuling C, Fehlner-Gardiner C, Kliemt J, Meslin FX, Franka R, Rupprecht CE, Tordo N, Wanderler AI, Kieny MP.

PLoS Negl Trop Dis. 2009 Nov 3;3(11):e542. doi: 10.1371/journal.pntd.0000542. Erratum in: PLoS Negl Trop Dis. 2009;3(11): doi: 10.1371/annotation/df98339d-6bdb-40ed-af83-cc38b249264a. Franka, Richard [added].

10.

Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus.

Faber M, Li J, Kean RB, Hooper DC, Alugupalli KR, Dietzschold B.

Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11300-5. doi: 10.1073/pnas.0905640106. Epub 2009 Jul 6.

11.

Concepts in the pathogenesis of rabies.

Dietzschold B, Li J, Faber M, Schnell M.

Future Virol. 2008 Sep;3(5):481-490.

12.

Intravenous inoculation of a bat-associated rabies virus causes lethal encephalopathy in mice through invasion of the brain via neurosecretory hypothalamic fibers.

Preuss MA, Faber ML, Tan GS, Bette M, Dietzschold B, Weihe E, Schnell MJ.

PLoS Pathog. 2009 Jun;5(6):e1000485. doi: 10.1371/journal.ppat.1000485. Epub 2009 Jun 19.

13.

Immunogenicity and safety of recombinant rabies viruses used for oral vaccination of stray dogs and wildlife.

Faber M, Dietzschold B, Li J.

Zoonoses Public Health. 2009 Aug;56(6-7):262-9. doi: 10.1111/j.1863-2378.2008.01215.x. Review.

PMID:
19486317
14.

Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.

Cenna J, Tan GS, Papaneri AB, Dietzschold B, Schnell MJ, McGettigan JP.

Vaccine. 2008 Nov 25;26(50):6405-14. doi: 10.1016/j.vaccine.2008.08.069. Epub 2008 Sep 18.

15.

Role of virus-induced neuropeptides in the brain in the pathogenesis of rabies.

Weihe E, Bette M, Preuss MA, Faber M, Schäfer MK, Rehnelt J, Schnell MJ, Dietzschold B.

Dev Biol (Basel). 2008;131:73-81.

PMID:
18634468
16.
17.
18.

Oral vaccination of raccoons (Procyon lotor) with genetically modified rabies virus vaccines.

Blanton JD, Self J, Niezgoda M, Faber ML, Dietzschold B, Rupprecht C.

Vaccine. 2007 Oct 16;25(42):7296-300. Epub 2007 Aug 22.

19.

Dominance of a nonpathogenic glycoprotein gene over a pathogenic glycoprotein gene in rabies virus.

Faber M, Faber ML, Li J, Preuss MA, Schnell MJ, Dietzschold B.

J Virol. 2007 Jul;81(13):7041-7. Epub 2007 Apr 25.

20.

Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.

McKenna PM, Koser ML, Carlson KR, Montefiori DC, Letvin NL, Papaneri AB, Pomerantz RJ, Dietzschold B, Silvera P, McGettigan JP, Schnell MJ.

J Infect Dis. 2007 Apr 1;195(7):980-8. Epub 2007 Feb 20.

PMID:
17330788
21.

Vaccination of small Asian mongoose (Herpestes javanicus) against rabies.

Blanton JD, Meadows A, Murphy SM, Manangan J, Hanlon CA, Faber ML, Dietzschold B, Rupprecht CE.

J Wildl Dis. 2006 Jul;42(3):663-6.

PMID:
17092899
22.

A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.

Li J, Faber M, Papaneri A, Faber ML, McGettigan JP, Schnell MJ, Dietzschold B.

Virology. 2006 Dec 5-20;356(1-2):147-54. Epub 2006 Aug 30.

23.

Rabies virus glycoprotein as a carrier for anthrax protective antigen.

Smith ME, Koser M, Xiao S, Siler C, McGettigan JP, Calkins C, Pomerantz RJ, Dietzschold B, Schnell MJ.

Virology. 2006 Sep 30;353(2):344-56. Epub 2006 Jul 3.

24.

Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin.

Goudsmit J, Marissen WE, Weldon WC, Niezgoda M, Hanlon CA, Rice AB, Kruif Jd, Dietzschold B, Bakker AB, Rupprecht CE.

J Infect Dis. 2006 Mar 15;193(6):796-801. Epub 2006 Feb 6.

PMID:
16479514
25.

Overexpression of tumor necrosis factor alpha by a recombinant rabies virus attenuates replication in neurons and prevents lethal infection in mice.

Faber M, Bette M, Preuss MA, Pulmanausahakul R, Rehnelt J, Schnell MJ, Dietzschold B, Weihe E.

J Virol. 2005 Dec;79(24):15405-16.

26.

A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity.

Faber M, Faber ML, Papaneri A, Bette M, Weihe E, Dietzschold B, Schnell MJ.

J Virol. 2005 Nov;79(22):14141-8.

27.

Enhanced humoral HIV-1-specific immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2.

McGettigan JP, Koser ML, McKenna PM, Smith ME, Marvin JM, Eisenlohr LC, Dietzschold B, Schnell MJ.

Virology. 2006 Jan 20;344(2):363-77. Epub 2005 Oct 14.

28.

Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants.

Bakker AB, Marissen WE, Kramer RA, Rice AB, Weldon WC, Niezgoda M, Hanlon CA, Thijsse S, Backus HH, de Kruif J, Dietzschold B, Rupprecht CE, Goudsmit J.

J Virol. 2005 Jul;79(14):9062-8.

29.

Pathogenesis of rabies.

Dietzschold B, Schnell M, Koprowski H.

Curr Top Microbiol Immunol. 2005;292:45-56. Review.

PMID:
15981467
30.

The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries.

Kramer RA, Marissen WE, Goudsmit J, Visser TJ, Clijsters-Van der Horst M, Bakker AQ, de Jong M, Jongeneelen M, Thijsse S, Backus HH, Rice AB, Weldon WC, Rupprecht CE, Dietzschold B, Bakker AB, de Kruif J.

Eur J Immunol. 2005 Jul;35(7):2131-45.

31.

Oral vaccination of dogs with recombinant rabies virus vaccines.

Rupprecht CE, Hanlon CA, Blanton J, Manangan J, Morrill P, Murphy S, Niezgoda M, Orciari LA, Schumacher CL, Dietzschold B.

Virus Res. 2005 Jul;111(1):101-5. Epub 2005 Apr 8.

PMID:
15896409
33.

Screening of organ and tissue donors for rabies.

Dietzschold B, Koprowski H.

Lancet. 2005 Apr 9-15;365(9467):1305. No abstract available.

PMID:
15823375
34.
35.

Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis.

Marissen WE, Kramer RA, Rice A, Weldon WC, Niezgoda M, Faber M, Slootstra JW, Meloen RH, Clijsters-van der Horst M, Visser TJ, Jongeneelen M, Thijsse S, Throsby M, de Kruif J, Rupprecht CE, Dietzschold B, Goudsmit J, Bakker AB.

J Virol. 2005 Apr;79(8):4672-8.

36.

Immunogenicity study of glycoprotein-deficient rabies virus expressing simian/human immunodeficiency virus SHIV89.6P envelope in a rhesus macaque.

McKenna PM, Aye PP, Dietzschold B, Montefiori DC, Martin LN, Marx PA, Pomerantz RJ, Lackner A, Schnell MJ.

J Virol. 2004 Dec;78(24):13455-9.

37.

In vitro growth and stability of recombinant rabies viruses designed for vaccination of wildlife.

Dietzschold ML, Faber M, Mattis JA, Pak KY, Schnell MJ, Dietzschold B.

Vaccine. 2004 Dec 9;23(4):518-24.

PMID:
15530701
38.

Identification of viral genomic elements responsible for rabies virus neuroinvasiveness.

Faber M, Pulmanausahakul R, Nagao K, Prosniak M, Rice AB, Koprowski H, Schnell MJ, Dietzschold B.

Proc Natl Acad Sci U S A. 2004 Nov 16;101(46):16328-32. Epub 2004 Nov 1.

39.

Rabies transmission from organ transplants in the USA.

Dietzschold B, Koprowski H.

Lancet. 2004 Aug 21-27;364(9435):648-9. No abstract available.

PMID:
15325815
40.

Neuropeptide Y up-regulation in cerebrocortical neurons after Borna Disease Virus infection is unrelated to brain inflammation in rats.

Bette M, Roehrenbeck A, Dietzschold B, Weihe E.

Neurosci Lett. 2004 Aug 12;366(2):197-200.

PMID:
15276246
41.

Rabies virus nucleoprotein as a carrier for foreign antigens.

Koser ML, McGettigan JP, Tan GS, Smith ME, Koprowski H, Dietzschold B, Schnell MJ.

Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9405-10. Epub 2004 Jun 14.

42.

Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseases.

McKenna PM, McGettigan JP, Pomerantz RJ, Dietzschold B, Schnell MJ.

Curr HIV Res. 2003 Apr;1(2):229-37. Review.

PMID:
15043205
43.

Glycoprotein of nonpathogenic rabies viruses is a major inducer of apoptosis in human jurkat T cells.

Lay S, Préhaud C, Dietzschold B, Lafon M.

Ann N Y Acad Sci. 2003 Dec;1010:577-81.

PMID:
15033795
44.
45.

Cell-type-specific gene delivery into neuronal cells in vitro and in vivo.

Parveen Z, Mukhtar M, Rafi M, Wenger DA, Siddiqui KM, Siler CA, Dietzschold B, Pomerantz RJ, Schnell MJ, Dornburg R.

Virology. 2003 Sep 15;314(1):74-83.

46.

Glycoprotein of nonpathogenic rabies viruses is a key determinant of human cell apoptosis.

Préhaud C, Lay S, Dietzschold B, Lafon M.

J Virol. 2003 Oct;77(19):10537-47.

47.

New approaches to the prevention and eradication of rabies.

Dietzschold B, Faber M, Schnell MJ.

Expert Rev Vaccines. 2003 Jun;2(3):399-406. Review.

PMID:
12903805
48.

Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies.

Prosniak M, Faber M, Hanlon CA, Rupprecht CE, Hooper DC, Dietzschold B.

J Infect Dis. 2003 Jul 1;188(1):53-6. Epub 2003 Jun 23.

PMID:
12825170
49.

Function and glycosylation of plant-derived antiviral monoclonal antibody.

Ko K, Tekoah Y, Rudd PM, Harvey DJ, Dwek RA, Spitsin S, Hanlon CA, Rupprecht C, Dietzschold B, Golovkin M, Koprowski H.

Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):8013-8. Epub 2003 Jun 10.

50.

Management of rabies in humans.

Jackson AC, Warrell MJ, Rupprecht CE, Ertl HC, Dietzschold B, O'Reilly M, Leach RP, Fu ZF, Wunner WH, Bleck TP, Wilde H.

Clin Infect Dis. 2003 Jan 1;36(1):60-3. Epub 2002 Dec 11.

PMID:
12491203

Supplemental Content

Loading ...
Support Center